249 related articles for article (PubMed ID: 18024953)
1. Emergence of Candida tropicalis resistant to caspofungin.
Pasquale T; Tomada JR; Ghannoun M; Dipersio J; Bonilla H
J Antimicrob Chemother; 2008 Jan; 61(1):219. PubMed ID: 18024953
[No Abstract] [Full Text] [Related]
2. Evaluation of the "Dip Effect" Phenomenon in Antifungal Susceptibility Testing of Candida spp. against Echinocandins by Use of Gradient Concentration Strips.
Siopi M; Tsala M; Siafakas N; Zerva L; Meletiadis J
J Clin Microbiol; 2015 Nov; 53(11):3654-9. PubMed ID: 26338855
[TBL] [Abstract][Full Text] [Related]
3. Caspofungin-non-susceptible Candida isolates in cancer patients.
Kofteridis DP; Lewis RE; Kontoyiannis DP
J Antimicrob Chemother; 2010 Feb; 65(2):293-5. PubMed ID: 20016020
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.
Ozkaya-Parlakay A; Tezer H; Kazmacan T; Gulhan B; Unal S
J Trop Pediatr; 2014 Aug; 60(4):329-30. PubMed ID: 24567311
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
del Castillo M; Wainsztein N; Klein F; Manganello S; Orellana N
Medicina (B Aires); 2004; 64(2):152-4. PubMed ID: 15628305
[TBL] [Abstract][Full Text] [Related]
6. Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Garcia-Effron G; Kontoyiannis DP; Lewis RE; Perlin DS
Antimicrob Agents Chemother; 2008 Nov; 52(11):4181-3. PubMed ID: 18794386
[TBL] [Abstract][Full Text] [Related]
7. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
[TBL] [Abstract][Full Text] [Related]
8. Invasive infection in an acute myeloblastic leukemia patient due to triazole-resistant Candida tropicalis.
de Carvalho Parahym AM; da Silva CM; Leão MP; Macario MC; Filho GA; de Oliveira NT; Neves RP
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):291-3. PubMed ID: 21924853
[TBL] [Abstract][Full Text] [Related]
9. First Case of Echinocandin-Resistant Candida albicans in Korea.
Park MS; Park JE; Song DJ; Huh HJ; Park S; Kang CI; Shin JH; Lee NY
Ann Lab Med; 2017 Nov; 37(6):556-558. PubMed ID: 28841000
[No Abstract] [Full Text] [Related]
10. Frequency of the Paradoxical Effect Measured Using the EUCAST Procedure with Micafungin, Anidulafungin, and Caspofungin against Candida Species Isolates Causing Candidemia.
Marcos-Zambrano LJ; Escribano P; Sánchez-Carrillo C; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799221
[TBL] [Abstract][Full Text] [Related]
11. Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.
Jensen RH; Johansen HK; Arendrup MC
Antimicrob Agents Chemother; 2013 Jan; 57(1):614-7. PubMed ID: 23089761
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of micafungin for the treatment of invasive candidiasis and candidaemia in patients with neutropenia.
Chandrasekar P; Sirohi B; Seibel NL; Hsu JW; Azie N; Wu C; Ruhnke M
Mycoses; 2018 May; 61(5):331-336. PubMed ID: 29364548
[TBL] [Abstract][Full Text] [Related]
13. [Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient].
Rome A; André N; Michel A; Coze C; Gentet JC; Bernard JL
Arch Pediatr; 2006 Dec; 13(12):1556-7. PubMed ID: 17049216
[No Abstract] [Full Text] [Related]
14. Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Forrest GN; Weekes E; Johnson JK
J Infect; 2008 Feb; 56(2):126-9. PubMed ID: 18082269
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin disk diffusion breakpoints and quality control.
Brown SD; Traczewski MM
J Clin Microbiol; 2008 Jun; 46(6):1927-9. PubMed ID: 18400918
[TBL] [Abstract][Full Text] [Related]
16. Caspofungin.
Parakh A; Dubey AP; Samanta D
Indian Pediatr; 2008 Nov; 45(11):905-10. PubMed ID: 19029563
[TBL] [Abstract][Full Text] [Related]
17. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
[TBL] [Abstract][Full Text] [Related]
18. Micafungin therapy in a critically ill, morbidly obese patient.
Zomp A; Bookstaver PB; Ahmed Y; Turner JE; King C
J Antimicrob Chemother; 2011 Nov; 66(11):2678-80. PubMed ID: 21810839
[No Abstract] [Full Text] [Related]
19. Candida tropicalis in human disease.
Chai LY; Denning DW; Warn P
Crit Rev Microbiol; 2010 Nov; 36(4):282-98. PubMed ID: 20883082
[TBL] [Abstract][Full Text] [Related]
20. In vivo studies with a Candida tropicalis isolate exhibiting paradoxical growth in vitro in the presence of high concentration of caspofungin.
Bayegan S; Majoros L; Kardos G; Kemény-Beke A; Miszti C; Kovacs R; Gesztelyi R
J Microbiol; 2010 Apr; 48(2):170-3. PubMed ID: 20437148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]